loadpatents
Patent applications and USPTO patent grants for Pepinsky; R. Blake.The latest application filed is for "humanized and stabilized fc5 variants for enhancement of blood brain barrier transport".
Patent | Date |
---|---|
Humanized And Stabilized Fc5 Variants For Enhancement Of Blood Brain Barrier Transport App 20220089704 - Smith; Benjamin A. ;   et al. | 2022-03-24 |
SP35 Antibodies And Uses Thereof App 20210395360 - Mi; Sha ;   et al. | 2021-12-23 |
SP35 Antibodies And Uses Thereof App 20200317775 - Mi; Sha ;   et al. | 2020-10-08 |
Use Of Lingo-4 Antagonists In The Treatment Of Conditions Involving Demyelination App 20200297800 - Mi; Sha ;   et al. | 2020-09-24 |
Dkk2 Cysteine Rich Domain 2 Containing Proteins And Uses Thereof App 20200270335 - Pepinsky; R. Blake ;   et al. | 2020-08-27 |
Stabilized Proteolytically Activated Growth Differentiation Factor 11 App 20200031895 - Pepinsky; R. Blake ;   et al. | 2020-01-30 |
Lingo-2 Antagonists For Treatment Of Conditions Involving Motor Neurons App 20190359706 - Mi; Sha ;   et al. | 2019-11-28 |
Methods of preventing and removing trisulfide bonds Grant 10,308,706 - Evans , et al. | 2019-06-04 |
SP35 Antibodies And Uses Thereof App 20190161546 - Mi; Sha ;   et al. | 2019-05-30 |
Use Of Lingo-4 Antagonists In The Treatment Of Conditions Involving Demyelination App 20190060398 - Mi; Sha ;   et al. | 2019-02-28 |
Lingo-2 Antagonists For Treatment Of Conditions Involving Motor Neurons App 20180111994 - Mi; Sha ;   et al. | 2018-04-26 |
LINGO-2 antagonists for treatment of conditions involving motor neurons Grant 9,796,780 - Mi , et al. October 24, 2 | 2017-10-24 |
Compositions comprising antibodies to LINGO or fragments thereof Grant 9,745,375 - Mi , et al. August 29, 2 | 2017-08-29 |
SP35 Antibodies And Uses Thereof App 20170037126 - Mi; Sha ;   et al. | 2017-02-09 |
Compositions Comprising Antibodies to Lingo or Fragments Thereof App 20160368984 - Mi; Sha ;   et al. | 2016-12-22 |
Use Of Lingo-4 Antagonists In The Treatment Of Conditions Involving Demyelination App 20160213745 - Mi; Sha ;   et al. | 2016-07-28 |
NOGO Receptor Antagonists App 20160159878 - Lee; Daniel H.S. ;   et al. | 2016-06-09 |
Compositions Comprising Antibodies to Lingo or Fragments Thereof App 20160083468 - Mi; Sha ;   et al. | 2016-03-24 |
Treatment Of Conditions Involving Demyelination App 20160002329 - Mi; Sha ;   et al. | 2016-01-07 |
Nogo receptor antagonists and methods of increasing neurite outgrowth Grant 9,228,015 - Lee , et al. January 5, 2 | 2016-01-05 |
SP35 Antibodies And Uses Thereof App 20150315273 - Mi; Sha ;   et al. | 2015-11-05 |
Methods of Preventing and Removing Trisulfide Bonds App 20150274808 - Evans; David ;   et al. | 2015-10-01 |
Use of DR6 and p75 Antagonists to Promote Survival of Cells of the Nervous System App 20150203585 - MI; Sha ;   et al. | 2015-07-23 |
Screening methods for identifying Sp35 antagonists Grant 9,068,992 - Mi , et al. June 30, 2 | 2015-06-30 |
Sp35 antibodies and uses thereof Grant 9,066,984 - Mi , et al. June 30, 2 | 2015-06-30 |
Nogo Receptor Binding Protein App 20150177240 - Mi; Sha ;   et al. | 2015-06-25 |
Lingo-2 Antagonists For Treatment Of Conditions Involving Motor Neurons App 20150118241 - Mi; Sha ;   et al. | 2015-04-30 |
Methods of preventing and removing trisulfide bonds Grant 9,005,926 - Evans , et al. April 14, 2 | 2015-04-14 |
Refolding transforming growth factor beta family proteins Grant 8,969,042 - Rossomando , et al. March 3, 2 | 2015-03-03 |
NOGO receptor binding protein Grant 8,932,821 - Mi , et al. January 13, 2 | 2015-01-13 |
Use of DR6 and p75 antagonists to promote survival of cells of the nervous system Grant 8,894,999 - Mi , et al. November 25, 2 | 2014-11-25 |
Refolding Transforming Growth Factor Beta Family Proteins App 20140322752 - Rossomando; Anthony ;   et al. | 2014-10-30 |
NOGO Receptor Antagonists App 20140227266 - Lee; Daniel H.S. ;   et al. | 2014-08-14 |
Sp35 Antibodies and Uses Thereof App 20140199315 - MI; Sha ;   et al. | 2014-07-17 |
NOGO receptor binding protein Grant 8,765,662 - Mi , et al. July 1, 2 | 2014-07-01 |
Refolding transforming growth factor beta family proteins Grant 8,722,862 - Rossomando , et al. May 13, 2 | 2014-05-13 |
Nogo receptor antagonists Grant 8,669,345 - Lee , et al. March 11, 2 | 2014-03-11 |
Polymer-conjugated glycosylated neublastin Grant 8,642,732 - Sah , et al. February 4, 2 | 2014-02-04 |
Use of DR6 and p75 Antagonists to Promote Survival of Cells of the Nervous System App 20140010826 - MI; Sha ;   et al. | 2014-01-09 |
Sp35 Antibodies and Uses Thereof App 20130336991 - MI; Sha ;   et al. | 2013-12-19 |
Sp35 antibodies and uses thereof Grant 8,609,407 - Mi , et al. December 17, 2 | 2013-12-17 |
Composition Comprising Antibodies to LINGO or Fragments Thereof App 20130323786 - MI; Sha ;   et al. | 2013-12-05 |
NOGO Receptor Binding Protein App 20130287693 - MI; SHA ;   et al. | 2013-10-31 |
Sp35 Antibodies and Uses Thereof App 20130287796 - MI; Sha ;   et al. | 2013-10-31 |
Treatment of Conditions Involving Demyelination App 20130273558 - MI; Sha ;   et al. | 2013-10-17 |
SP35 antibodies and uses thereof Grant 8,551,476 - Mi , et al. October 8, 2 | 2013-10-08 |
Polyalkylene polymer compounds and uses thereof Grant 8,524,660 - Lin , et al. September 3, 2 | 2013-09-03 |
Use of DR6 and p75 antagonists to promote survival of cells of the nervous system Grant 8,501,178 - Mi , et al. August 6, 2 | 2013-08-06 |
Treatment of conditions involving demyelination Grant 8,486,893 - Mi , et al. July 16, 2 | 2013-07-16 |
Composition comprising antibodies to LINGO or fragments thereof Grant 8,425,910 - Mi , et al. April 23, 2 | 2013-04-23 |
Neublastin Variants App 20130096065 - Rossomando; Anthony ;   et al. | 2013-04-18 |
Functional antagonists of hedgehog activity Grant 8,410,061 - Williams , et al. April 2, 2 | 2013-04-02 |
Polymer-conjugated Glycosylated Neublastin App 20120316109 - Sah; Dinah Wen-Yee ;   et al. | 2012-12-13 |
Methods of Preventing and Removing Trisulfide Bonds App 20120264916 - Evans; David ;   et al. | 2012-10-18 |
NOGO Receptor Binding Protein App 20120230979 - MI; Sha ;   et al. | 2012-09-13 |
Neublastin variants Grant 8,263,553 - Rossomando , et al. September 11, 2 | 2012-09-11 |
Sp35 Antibodies and Uses Thereof App 20120190070 - MI; Sha ;   et al. | 2012-07-26 |
Use of DR6 and p75 Antagonists to Promote Survival of Cells of the Nervous System App 20120141456 - Mi; Sha ;   et al. | 2012-06-07 |
Polymer conjugated glycosylated neublastin Grant 8,163,875 - Sah , et al. April 24, 2 | 2012-04-24 |
Nogo receptor binding protein Grant 8,153,580 - Mi , et al. April 10, 2 | 2012-04-10 |
Sp35 antibodies and uses thereof Grant 8,128,926 - Mi , et al. March 6, 2 | 2012-03-06 |
Polymer conjugates of mutated neublastin Grant 8,119,114 - Sah , et al. February 21, 2 | 2012-02-21 |
Polyalkylene Polymer Compounds And Uses Thereof App 20120014916 - Lin; KoChung ;   et al. | 2012-01-19 |
Composition Comprising Antibodies to LINGO or Fragments Thereof App 20120014960 - MI; Sha ;   et al. | 2012-01-19 |
Sp35 Antibodies and Uses Thereof App 20110311542 - MI; SHA ;   et al. | 2011-12-22 |
Composition comprising antibodies to LINGO or fragments thereof Grant 8,058,406 - Mi , et al. November 15, 2 | 2011-11-15 |
Nogo receptor antagonists Grant 8,030,456 - Lee , et al. October 4, 2 | 2011-10-04 |
Polyalkylene polymer compounds and uses thereof Grant 8,017,733 - Lin , et al. September 13, 2 | 2011-09-13 |
Use of LINGO-4 Antagonists in the Treatment of Conditions Involving Demyelination App 20110123553 - Mi; Sha ;   et al. | 2011-05-26 |
Nogo receptor binding protein Grant 7,785,829 - Mi , et al. August 31, 2 | 2010-08-31 |
NOGO Receptor Binding Protein App 20100204304 - Mi; Sha ;   et al. | 2010-08-12 |
Compositions And Methods For Administering Gdnf Ligand Family Proteins App 20100056440 - Rossomando; Anthony ;   et al. | 2010-03-04 |
Composition Comprising Antibodies to LINGO or Fragments Thereof App 20100015131 - MI; Sha ;   et al. | 2010-01-21 |
Sp35 Antibodies and Uses Thereof App 20090252748 - MI; Sha ;   et al. | 2009-10-08 |
NOGO Receptor Antagonists App 20090215691 - Lee; Daniel H.S. ;   et al. | 2009-08-27 |
Treatment of Conditions Involving Demyelination App 20090175872 - Mi; Sha ;   et al. | 2009-07-09 |
Oligodendrocyte-Myelin Glycoprotein Compositions and Methods of Use Thereof App 20090175846 - Mi; Sha ;   et al. | 2009-07-09 |
Nogo Receptor Antagonists App 20090099078 - Lee; Daniel H.S. ;   et al. | 2009-04-16 |
Nogo Receptor Polypeptides and Polypeptide Fragments and Uses Thereof App 20090062199 - Wen; Dingyi ;   et al. | 2009-03-05 |
Hydrophobically-modified protein compositions and methods App 20090054632 - Pepinsky; R. Blake ;   et al. | 2009-02-26 |
SP35 Antibodies and uses thereof App 20090017039 - Mi; Sha ;   et al. | 2009-01-15 |
Nogo receptor antagonists Grant 7,465,705 - Lee , et al. December 16, 2 | 2008-12-16 |
Polymer Conjugates Of Mutated Neublastin App 20080306212 - Sah; Dinah Wen-Yee ;   et al. | 2008-12-11 |
Nogo Receptor Antagonists App 20080274112 - Lee; Daniel H.S. ;   et al. | 2008-11-06 |
Polymer conjugates of mutated neublastin Grant 7,442,370 - Sah , et al. October 28, 2 | 2008-10-28 |
Refolding Transforming Growth Factor Beta Family Proteins App 20080249287 - Rossomando; Anthony ;   et al. | 2008-10-09 |
Neublastin Variants App 20080039385 - Rossomando; Anthony ;   et al. | 2008-02-14 |
Polymer-Conjugated Glycosylated Neublastin App 20070238650 - Sah; Dinah Wen-Yee ;   et al. | 2007-10-11 |
Cell adhesion inhibitors Grant 7,196,112 - Lee , et al. March 27, 2 | 2007-03-27 |
Cell adhesion inhibitors App 20070066533 - Lee; Wen-Cherng ;   et al. | 2007-03-22 |
Nogo receptor binding protein App 20070059793 - Mi; Sha ;   et al. | 2007-03-15 |
Cell adhesion inhibitors App 20060014966 - Lee; Wen-Cherng ;   et al. | 2006-01-19 |
Treatment of conditions involving demyelination App 20060009388 - Mi; Sha ;   et al. | 2006-01-12 |
Nogo receptor antagonists App 20050271655 - Lee, Daniel H.S. ;   et al. | 2005-12-08 |
Polymer conjugates of mutated neublastin App 20050142098 - Sah, Dinah Wen-Yee ;   et al. | 2005-06-30 |
Hydrophobically-modified protein compositions and methods App 20050119181 - Pepinsky, R. Blake ;   et al. | 2005-06-02 |
Hydrophobically-modified protein compositions and methods Grant 6,897,297 - Pepinsky , et al. May 24, 2 | 2005-05-24 |
Polyalkylene polymer compounds and uses thereof App 20050107277 - Lin, KoChung ;   et al. | 2005-05-19 |
Polymer conjugates of hedgehog proteins and uses App 20040038876 - Pepinsky, R. Blake ;   et al. | 2004-02-26 |
Functional antagonists of hedgehog activity App 20030166543 - Williams, Kevin ;   et al. | 2003-09-04 |
Hydrophobically-modified hedgehog protein compositions and methods Grant 6,444,793 - Pepinsky , et al. September 3, 2 | 2002-09-03 |
Tat-derived transport polypeptides Grant 6,316,003 - Frankel , et al. November 13, 2 | 2001-11-13 |
Muteins of IFN-.beta. Grant 6,127,332 - Goelz , et al. October 3, 2 | 2000-10-03 |
Tat-derived transport polypeptides and fusion proteins Grant 5,804,604 - Frankel , et al. September 8, 1 | 1998-09-08 |
Tat-derived transport polypeptide conjugates Grant 5,747,641 - Frankel , et al. May 5, 1 | 1998-05-05 |
Fusion protein comprising tat-derived transport moiety Grant 5,674,980 - Frankel , et al. October 7, 1 | 1997-10-07 |
Nucleic acid conjugates of tat-derived transport polypeptides Grant 5,670,617 - Frankel , et al. September 23, 1 | 1997-09-23 |
Nucleic acids encoding and methods of making tat-derived transport polypeptides Grant 5,652,122 - Frankel , et al. July 29, 1 | 1997-07-29 |
Muteins of IFN-.beta. Grant 5,545,723 - Goelz , et al. August 13, 1 | 1996-08-13 |
DNA sequences, recombinant DNA molecules and processes for producing lipocortin-like polypeptides Grant 5,081,019 - Wallner , et al. January 14, 1 | 1992-01-14 |
DNA sequences, recombinant DNA molecules and processes for producing human phospholipase inhibitor polypeptides Grant 4,879,224 - Wallner , et al. November 7, 1 | 1989-11-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.